Nasdaq

Independent multi-center trial shows that Getinge's NAVA ventilation mode shortens time of mechanical ventilation by almost 35% for adult ICU patients

GOTHENBURG, Sweden, Sept. 30, 2020 /PRNewswire/ -- The clinical effectiveness of Getinge's patented Neurally Adjusted Ventilatory Assist (NAVA), which uses the patient's own respiratory drive to ...
Nature

The impact of neurally adjusted ventilatory assist mode on respiratory severity score and energy expenditure in infants: a randomized crossover trial

Examine respiratory severity scores (RSS) (mean airway pressure × fraction of inspired oxygen) and resting energy expenditure (REE) on neurally adjusted ventilatory assist (NAVA) compared with ...
Nasdaq

The ventilation technology from Getinge that is groundbreaking both for premature babies and adults

GOTHENBURG, Sweden, Sept. 30, 2020 /PRNewswire/ -- Born 12 weeks too early with a 50/50 chance at survival, Sabina Checketts has grown up to become a neonatal doctor herself, using new therapies and ...
Yahoo Finance

Neonatal Ventilator Market Research Report 2026-2031: Increasing Adoption of NAVA, and Shift Towards Non-Invasive & Hybrid Ventilators

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Mena FN

Neonatal Ventilator Market Research Report 2026-2031: Increasing Adoption Of NAVA, And Shift Towards Non-Invasive & Hybrid Ventilators

(MENAFN- GlobeNewsWire - Nasdaq) The global neonatal ventilators market is projected to grow at a CAGR of 4.63% between 2025 and 2031. Key segments include consumables & accessories, non-invasive ...